Back to Agenda
Unleashing Biopharma Potential: Maximizing Consortia Engagement with Strategic Change Management
Session Chair(s)
John Richard Dobbins, MEd
Program Manager, Portfolio Change Management
Transcelerate Biopharma Inc., United States
Through strong sponsorship, stakeholder management, and communication practices, many companies have been more effective at bringing innovation and new learnings from external organizations and consortia back into their respective companies.
Learning Objective : Recognize how dedicating resources can enable your organization to enhance talent and innovation, increase value, and maximize your investment in consortia participation; Discuss the application of best practices around communicating new solutions/tools and events to the right internal stakeholders to maximize uptake; Describe building a coalition of internal champions to support collaboration.
Speaker(s)
Industry Update
Sarah Tremethick
Roche Products Limited, United Kingdom
Global Consortia Program Lead, Product Development Industry Collaborations
Industry Update
Toni Spears, BSN
Sanofi, United States
Program Lead, Industry Collaborations
Industry Update
John Z. Sun, PhD, MBA, PMP
Novartis Pharmaceuticals Corporation, United States
Program Lead, Global Clinical Operation, Development
Have an account?